CDC Website CDC Website

To Join the NPIN community or

Home » DoD Peer Reviewed Medical, Clinical Trial Award

DoD Peer Reviewed Medical, Clinical Trial Award

The FY23 PRMRP Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in one of the congressionally directed FY23 PRMRP Topic Areas and FY23 PRMRP Strategic Goals. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations. Funding from this award mechanism must support a clinical trial. A clinical trial is defined as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.

Funding Organization
The US Department of Defense Dept. of the Army -- USAMRAA
Funding Category
Other Health-Related
Support Types
Cooperative Agreements
Eligible Organizations
Number of Awards Given
9 Awards
Application Due Date
Application Contact Contact Center
800-518-4726; International 1-606-545-5035
Technical Contact
CDMRP Help Desk
Clinical Research
Data Analysis
Health Care Planning
Health Care Programs/Services
Medical Treatments and Therapies
At Risk Persons
Community Based Organizations
Health Professionals
Health Services Organizations

Fund Number: 


Fund ID: 


Last modified: